Products - Structural heart defects | Topic | NICE

Showing 5 products

Date | Title

Status: In developmentRemove ‘Status: In development’ filter

Acoramidis for treating transthyretin-related amyloidosis cardiomyopathy [ID6354]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
11 December 2025
Vutrisiran for treating transthyretin-related amyloidosis cardiomyopathy [ID6470]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
28 January 2026
Off-pump minimal access mitral valve repair by artificial chordae insertion to treat mitral regurgitation in adults
Status:
In development
Programme:
Interventional procedures guidance
Expected publication date:
4 March 2026
Transcatheter tricuspid valve implantation for tricuspid regurgitation
Status:
In development
Programme:
Interventional procedures guidance
Expected publication date:
4 March 2026
Mavacamten for treating symptomatic non-obstructive hypertrophic cardiomyopathy [ID6523]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC